Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

Quercetin effectively treated and prevented hair loss in mice.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

The effectiveness of alternative treatments for alopecia areata is uncertain and needs more research.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Acyzol could help treat conditions caused by zinc deficiency.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Hair area varies with age and sex, but hair index and medullary index do not.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Extracts from Alnus sibirica and oregonin may help with hair growth and prevent hair loss.

Michael L. Beehner proposed a standardized way to describe balding areas on the scalp to help hair restoration experts communicate better.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Using extracellular vesicles from stem cells can help hair grow by affecting scalp cells and hair follicles.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Kampo medicine can help treat general fatigue from long COVID.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.